NR4A1 and breast cancer: Loss of NR4A1 inhibits TGF-β-induced epithelial-to-mesenchymal transition (EMT), revealing a novel mechanism by which the microenvironment stimulates breast cancer cell invasion and metastasis (Zhou et al., 2014).